Navigation Links
Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show
Date:11/8/2007

g Study FMS-031 also met the composite syndrome responder criteria

at three months (33% and 33% for the milnacipran 100 mg and 200 mg

groups, respectively) compared to patients treated with placebo (17%).

Statistically significant differences were also observed at the six-

month visit: 33% and 32% of patients met responder criteria for the

milnacipran 100 mg and 200 mg groups, respectively, compared to 19% of

patients in the placebo group.

Composite responder rates for fibromyalgia pain (pain and PGIC)

-- A statistically significant number of patients treated with milnacipran

during Study MLN-MD-02 met the composite pain responder criteria (39%

and 46% in the milnacipran 100 mg and 200 mg groups, respectively)

compared to patients treated with placebo (25%).

-- A statistically significant number of patients treated with milnacipran

during Study FMS-031 also met the composite pain responder criteria at

three months (45% and 45% in the milnacipran 100 mg and 200 mg groups,

respectively) compared to patients treated with placebo (27%).

Statistically significant differences were also observed at the six-

month visit: 44% and 45% of patients met the composite pain responder

criteria in the milnacipran 100 mg and 200 mg groups, respectively,

compared to 28% of patients in placebo group.

Tolerability

Milnacipran was generally well-tolerated, with the majority of adverse events (AEs) reported being mild to moderate in nature.

-- The most common treatment emergent AEs during the placebo-controlled

clinical trials included nausea (37% vs. 20% placebo), headache (18%

vs. 14% placebo), constipation (16% vs. 4% placebo), hot flushes (12%

vs. 2% placebo), hyperhidrosis (9% vs. 2 % placebo), vomiting (7% vs.

2%), palpitations (7% vs. 2%), heart rate increase (6% vs. 1
'/>"/>

SOURCE Forest Laboratories, Inc. and Cypress Bioscience, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
2. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
3. Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
4. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
5. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... -- Obsidian HDS, the developer of PharmaShine ( www.pharmashine.com ... of data on pharmaceutical and device industry payments to ... 2014 Open Payments General and Research data released by ... data disclosed on Open Payments for 2014 includes information ... $6.49 billion and is the largest public disclosure of ...
(Date:7/2/2015)... Chine, 3 juillet 2015 BGI a annoncé ... débit de l,ADN situé à Hong ... l,American College of Pathologists  (Collège des pathologistes américains, ... Hong Kong constituent le premier ... recevoir la certification du CAP en Chine, car ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
(Date:7/4/2015)... ... 04, 2015 , ... Chronic Neck Pain. Neck pain is no ... in the neck. Another 19% suffer from head, migraine, or facial pain, in some ... 45% of American workers must deal with neck pain. Strategies for mitigating ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer of ... expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and is ... respected and well established national certification organization for renewable energy professionals. Designation as ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon ... 2nd creating a buzz of media attention. In an effort to spread the ... Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress and ...
(Date:7/3/2015)... SC (PRWEB) , ... July ... ... has announced the sessions and speaker lineup for its 2015 Annual ... taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld in ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and ... 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, ... held at the Westin Galleria Dallas. , Designed to take participants from the basic ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3
... chief of Renal Medicine and director of the Nephrology ... of medicine at Boston University School of Medicine (BUSM) ... Castle Connolly Medical Ltd. , The America,s Top Doctors ... a trusted and authoritative resource for identifying top doctors ...
... To improve the quality of the rapidly expanding array ... entered into a Memorandum of Understanding (MOU) with the ... for Biological Standards and Control (NIBSC) of the United ... plants or animals, rather than those created in a ...
... related to quality of marriage relationship, , , THURSDAY, Dec. ... poorer outcomes for women with breast cancer, a new ... in troubled marriages had higher levels of stress, less ... of illness than women who reported good marriages. ...
... men with chronic prostatitis, a painful disorder of the ... symptoms in recently diagnosed men who had not been ... trial sponsored by the National Institute of Diabetes and ... Institutes of Health (NIH). The study is to be ...
... Society has worked out new guidelines for the diagnosis ... Malignant melanoma is responsible for 90% of deaths from ... last 30 years and UV radiation is thought to ... , Claus Garbe of Tbingen University and his ...
... time with kids is one option to consider , , THURSDAY, ... be important considerations when you,re looking for children,s Christmas gifts, ... Philadelphia. , "Parents often feel like they have to ... chairman and professor of occupational therapy, said in a university ...
Cached Medicine News:Health News:Marital Distress May Affect Breast Cancer Recovery 2Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:'Hot' Toys May Not Be the Best Present 2
Architect ci8200 is a flexible solution for your evolving laboratory offering high productivity, one report and one operator interface for both chemistry and immunoassay testing....
... The Bayer Immuno 1 ... access immunoassay instrument with over ... reproductive endocrinology, tumor marker, therapeutic ... testing can be performed on ...
The UniCel DxI 800 with its exceptional throughput, proven chemiluminescent technology, assay protocols like Access, Access 2, Synchron LXi 725 and load "on-the-fly" capability simplifies and automat...
... The Access immunoassay ... random access benchtop analyzer ... of assays, with panels ... reproductive, thyroid, infectious disease, ...
Medicine Products: